STAA logo

STAA STAAR Surgical Company

NASDAQ Global Market · Medical - Instruments & Supplies · Healthcare

$24.22
-0.81 (-3.24%)

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct variou…

Market Cap: $1.22Bwww.staar.com

Price

No data yet.

Social Signal Score

53
5d
—
30d
50
3 mentions
—
60d
53
6 mentions
—
90d
55
7 mentions
—
news: 7

Analyst Ratings

16 analysts
Holdconsensus
Strong Buy 0Buy 5Hold 9Sell 2Strong Sell 0
Avg price target$30.25+24.9%
Low $23Median $32High $34
Current Consensus

Revenue

$83.41M+276.79%
$20.35M$46.57M$72.79M$99.00M
Dec 2016Oct 2026

Analyst Estimates

FY2026
$0.02
$0.02–$0.02
3 analysts
FY2027
$0.35+1437% YoY
$0.34–$0.35
5 analysts
FY2028
$0.58+69% YoY
$0.54–$0.61
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Warren Foust
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
921
Beta
1.20
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
7.72
www.staar.com